客户访谈
Using NGS to Study Rare Undiagnosed Genetic Disease
Whole-exome and transcriptome sequencing prove beneficial in uncovering mutations and pathways associated with rare disease.
阅读文章
客户视频
Bringing all the omics together
Dr. Szilard Voros, CEO of Global Genomics Group (G3), shares how he and his team of researchers embarked on an ambitious journey to transform...
观看视频
| 日期 | 发表 | 标题 |
|---|---|---|
| 2019-10-9 | Yahoo! Finance | Illumina Inks Deal to Commercialize NGS-Based IVD Kits |
| 2019-9-30 | ClinicalOMICs | Illumina and the Broad Co-Developing Open-Source Secondary Analysis Software |
| 2019-2-27 | Bloomberg | A $100 Genome Within Reach, Illumina CEO Asks If World Is Ready |